| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
forkhead box C1 | 0.483 | 0.846 | 0.95 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1988 | 2018 | ||||||||
|
integrin subunit alpha 1 | 0.644 | 0.654 | 2.6E-16 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1988 | 2019 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 0.705 | 0.500 | 0.89 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 1988 | 2013 | ||||||||
|
ATP binding cassette subfamily C member 6 | 0.540 | 0.654 | 5.6E-35 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2017 | ||||||||
|
integrin subunit alpha L | 0.511 | 0.885 | 4.3E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2016 | ||||||||
|
integrin subunit beta 2 | 0.444 | 0.923 | 5.1E-15 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2009 | ||||||||
|
p21 (RAC1) activated kinase 3 | 0.569 | 0.731 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2017 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1 | 0.760 | 0.346 | 4.1E-28 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.700 | None | 0.975 | 1014 | 8 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 575 | 7 | 1989 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.976 | 247 | 1 | 1989 | 2020 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.100 | None | 0.890 | 200 | 1 | 1989 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.600 | None | 0.955 | 199 | 1 | 1989 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.400 | None | 1.000 | 39 | 0 | 1989 | 2019 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
disease | 0.400 | None | 1.000 | 36 | 0 | 1989 | 2020 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.880 | 25 | 0 | 1989 | 2019 | |||||||||
|
CD68 molecule | 0.408 | 0.808 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1989 | 2015 | ||||||||
|
major histocompatibility complex, class II, DR beta 4 | 0.565 | 0.846 |
|
disease | 0.100 | None | 0.800 | 10 | 0 | 1989 | 2019 | |||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 1989 | 2018 | ||||||||
|
complement C4B (Chido blood group) | 0.603 | 0.808 | 0.83 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1989 | 2012 | ||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1989 | 1992 | |||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1989 | 1992 | ||||||||
|
TNF receptor superfamily member 10a | 0.521 | 0.731 | 5.1E-15 |
|
disease | 0.050 | None | 0.800 | 5 | 1 | 1989 | 2012 | ||||||||
|
cyclin dependent kinase inhibitor 2D | 0.547 | 0.769 | 0.49 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1989 | 2009 |